Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.

Harris KM, Lenz P, Hankey KG, MacVittie T, Farese A, Nakajima K, Hasumi K, Mann DL.

Clin Immunol. 2008 Oct;129(1):58-68. doi: 10.1016/j.clim.2008.06.003. Epub 2008 Aug 8.

PMID:
18691939
[PubMed - indexed for MEDLINE]
2.

Monophosphoryl lipid A activates both human dendritic cells and T cells.

Ismaili J, Rennesson J, Aksoy E, Vekemans J, Vincart B, Amraoui Z, Van Laethem F, Goldman M, Dubois PM.

J Immunol. 2002 Jan 15;168(2):926-32.

PMID:
11777991
[PubMed - indexed for MEDLINE]
Free Article
3.

In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.

Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, Leis J, Maziarz RT, Tiberghien P, Berenson RJ.

J Immunol. 2005 Feb 15;174(4):2366-75.

PMID:
15699173
[PubMed - indexed for MEDLINE]
Free Article
4.

Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells.

Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, Novarino A, Stacchini A, Bertetto O, Palestro G, Sorio C, Scarpa A, Emanuelli G, Rodeck U.

J Immunol. 2006 Sep 1;177(5):3448-60.

PMID:
16920987
[PubMed - indexed for MEDLINE]
Free Article
5.

Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.

Shibuya TY, Wei WZ, Zormeier M, Ensley J, Sakr W, Mathog RH, Meleca RJ, Yoo G, June CH, Levine B, Lum LG.

Arch Otolaryngol Head Neck Surg. 1999 Nov;125(11):1229-34.

PMID:
10555694
[PubMed - indexed for MEDLINE]
6.

T-cell-conditioned medium efficiently induces the maturation and function of human dendritic cells.

Kato K, Takaue Y, Wakasugi H.

J Leukoc Biol. 2001 Dec;70(6):941-9.

PMID:
11739557
[PubMed - indexed for MEDLINE]
Free Article
7.

Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function.

Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S.

Am J Clin Nutr. 2004 Dec;80(6):1618-25.

PMID:
15585777
[PubMed - indexed for MEDLINE]
Free Article
8.

Analysis of anthrax and plague biowarfare vaccine interactions with human monocyte-derived dendritic cells.

Skowera A, de Jong EC, Schuitemaker JH, Allen JS, Wessely SC, Griffiths G, Kapsenberg M, Peakman M.

J Immunol. 2005 Dec 1;175(11):7235-43.

PMID:
16301628
[PubMed - indexed for MEDLINE]
Free Article
9.

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.

Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M.

J Immunother. 2004 Sep-Oct;27(5):405-18.

PMID:
15314550
[PubMed - indexed for MEDLINE]
10.

The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.

Kemp RA, Bäckström BT, Ronchese F.

Immunology. 2005 Jul;115(3):315-24.

PMID:
15946249
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.

Zahorchak AF, Kean LS, Tokita D, Turnquist HR, Abe M, Finke J, Hamby K, Rigby MR, Larsen CP, Thomson AW.

Transplantation. 2007 Jul 27;84(2):196-206.

PMID:
17667811
[PubMed - indexed for MEDLINE]
12.

IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro.

Egan JE, Quadrini KJ, Santiago-Schwarz F, Hadden JW, Brandwein HJ, Signorelli KL.

J Immunother. 2007 Sep;30(6):624-33.

PMID:
17667526
[PubMed - indexed for MEDLINE]
13.
14.

Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy.

Onlamoon N, Hudson K, Bryan P, Mayne AE, Bonyhadi M, Berenson R, Sundstrom BJ, Bostik P, Ansari AA, Villinger F.

J Med Primatol. 2006 Aug;35(4-5):178-93.

PMID:
16872281
[PubMed - indexed for MEDLINE]
15.

CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen.

Kaiser A, Donnadieu E, Abastado JP, Trautmann A, Nardin A.

J Immunol. 2005 Aug 15;175(4):2349-56.

PMID:
16081805
[PubMed - indexed for MEDLINE]
Free Article
16.

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine.

Haas C, Lulei M, Fournier P, Arnold A, Schirrmacher V.

Vaccine. 2005 Mar 31;23(19):2439-53.

PMID:
15752830
[PubMed - indexed for MEDLINE]
17.

Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.

Lenz P, Lowy DR, Schiller JT.

Eur J Immunol. 2005 May;35(5):1548-56.

PMID:
15832296
[PubMed - indexed for MEDLINE]
18.

Cytotoxic difference of T cells expanded with anti-CD3 monoclonal antibody in the presence and absence of anti-CD 28 monoclonal antibody.

Yamada-Ohnishi Y, Azuma H, Urushibara N, Yamaguchi M, Fujihara M, Kobata T, Ikeda H.

Stem Cells Dev. 2004 Jun;13(3):315-22.

PMID:
15186727
[PubMed - indexed for MEDLINE]
19.

Immunological effects of BCG as an adjuvant in autologous tumor vaccines.

Li Q, Normolle DP, Sayre DM, Zeng X, Sun R, Jiang G, Redman BD, Chang AE.

Clin Immunol. 2000 Jan;94(1):64-72.

PMID:
10607491
[PubMed - indexed for MEDLINE]
20.

Development of novel substrates for tumor immunotherapy.

Shalaby WS, Yeh H, Woo E, Hendren S, Corbett JT, Gray H, June CH, Shalaby SW.

J Control Release. 2003 Aug 28;91(1-2):209-24.

PMID:
12932653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk